Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Indications  





2 Synthesis  





3 References  














Quifenadine






العربية
فارسی
Русский
Српски / srpski
Srpskohrvatski / српскохрватски
Українська
Tiếng Vit
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Quifenadine
Clinical data
Trade namesFencarol
Other names3-Quinuclidinyldiphenylmethanol
Routes of
administration
Oral (tablets), IM injection
ATC code
Legal status
Legal status
  • OTC (tablets), Rx-only (solution for IM injection) (RU)
Pharmacokinetic data
Bioavailability45% (Tmax = 1 hour)[1]
MetabolismLiver
Identifiers
  • 1-Azabicyclo[2.2.2]octan-3-yl(diphenyl)methanol

CAS Number
  • HCl: 10447-38-8 checkY
  • PubChem CID
    ChemSpider
    UNII
  • HCl: 6WSK4828LL checkY
  • KEGG
    ChEMBL
    CompTox Dashboard (EPA)
    Chemical and physical data
    FormulaC20H23NO
    Molar mass293.410 g·mol−1
    3D model (JSmol)
    • OC(c1ccccc1)(c2ccccc2)C4C3CCN(CC3)C4

    • InChI=1S/C20H23NO/c22-20(17-7-3-1-4-8-17,18-9-5-2-6-10-18)19-15-21-13-11-16(19)12-14-21/h1-10,16,19,22H,11-15H2

    • Key:PZMAHNDJABQWGS-UHFFFAOYSA-N

    Quifenadine (Russian: хифенадин, trade name: Phencarol, Фенкарол) is a 2nd generation antihistamine drug, marketed mainly in post-Soviet countries.[2][3] Chemically, it is a quinuclidine derivative.

    The drug has antiarrhythmic properties, probably due to the presence of a quinuclidine nucleus in the molecule's core. It acts as a calcium channel blocker and influences the activity of potassium channels.[clarification needed] In children with cardiac arrhythmia, combination therapy with quifenadone and either amiodaroneorpropafenone was found to be more effective than monotherapy with either amiodarone or propafenone.[4]

    Quifenadine is a derivative of quinuclidylcarbinol, which reduces the effects of histamine on organs and systems. Quifenadine is a competitive blocker of H1 receptors. In addition, it activates the diamine oxidase enzyme, which breaks down about 30% of endogenous histamine. This explains the effectiveness of quifenadine in patients insensitive to other antihistamines. The antihistaminic qualities of quifenadine are associated with the presence of a cyclic quinuclidine core in the structure and the distance between the diphenylcarbinol group and the nitrogen atom. In terms of antihistaminic activity and duration of action, quifenadine is superior to diphenhydramine. Quifenadine reduces the toxic effect of histamine, eliminates or weakens its bronchoconstrictor effect and spasmodic effect on the smooth muscles of the intestines, has a moderate antiserotonin and weak cholinolytic effect, has well-defined antipruritic and desensitizing properties. Quifenadine weakens the hypotensive effect of histamine and its effect on capillary permeability, does not directly affect cardiac activity and blood pressure, does not have a protective effect in aconitine arrhythmias.[5]

    Indications[edit]

    Synthesis[edit]

    Same precursor as for mequitazine. Use patent:[6]

    Synthesis:[7] Patent:[8] Prec:[9][10]

    The Grignard reaction between methylquinuclidine-3-carboxylate [38206-86-9] (1) and phenylmagnesium bromide (2) gave the benzhydryl alcohol product ~29% yield. The ethyl ester is cas: [6238-33-1]

    References[edit]

    1. ^ a b "Fencarol (quifenadine) Tablets, for Oral Use. Full Prescribing Information". State Register of Medicines (in Russian). Retrieved 4 January 2016.
  • ^ "Quifenadine". Drugs.com. Retrieved 28 January 2014.
  • ^ Makarov L, Balykova L, Soldatova O, Komolyatova V, Serebruany V (2010). "The antiarrhythmic properties of quifenadine, H1-histamine receptor blocker in children with premature beats: a randomized controlled pilot trial". American Journal of Therapeutics. 17 (4): 396–401. doi:10.1097/MJT.0b013e3181a86987. PMID 19487925. S2CID 43654011.
  • ^ Soldatova ON, Balykova LA, Makarov LM, Komolyatova VN, Chuprova SN, Soldatov OM, Kornilova TI (2008-09-01). "Эффективность Фенкарола В Сочетании С Традиционными Противоаритмическими Средствами При Экстрасистолии У Детей" [Effectiveness of Fencarol in Combination With Traditional Anti-Arithmic Medicines in Children With Extrasystole]. RUDN Journal of Medicine (in Russian) (3): 46–51. ISSN 2313-0245. Archived from the original on 20 November 2020. Retrieved 18 November 2020.
  • ^ "Quifenadine". compendium.com.ua. Retrieved 24 July 2022.
  • ^ Mikhail Davydovich Mashkovsky, et al. U.S. patent 4,117,139 (1978).
  • ^ Lainé DI, McCleland B, Thomas S, Neipp C, Underwood B, Dufour J, et al. (April 2009). "Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists". Journal of Medicinal Chemistry. 52 (8): 2493–2505. doi:10.1021/jm801601v. PMID 19317446.
  • ^ Micail Emmanuilovic Kaminka, DE 2502916  (1975 to VSESOJUZNYJ NAUCNO-ISSLEDOVATEL'SKIJ CHIMIKO-FARMACEVTICESKIJ INSTITUT IMENI SERGO ORDZONIKIDZE MOSKAU/MOSKVA SU).
  • ^ , U.S. patent 2,901,486 (1959).
  • ^ Harry J. Wadsworth, et al. U.S. patent 5,091,397 (1992 to Beecham Group PLC).
  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Quifenadine&oldid=1203093336"

    Categories: 
    Quinuclidines
    Antihistamines
    Tertiary alcohols
    Russian drugs
    Antiarrhythmic agents
    Drugs in the Soviet Union
    Respiratory system drug stubs
    Hidden categories: 
    CS1 Russian-language sources (ru)
    Articles with short description
    Short description matches Wikidata
    Science and technology articles needing translation from Russian Wikipedia
    Drugs with non-standard legal status
    Chemical pages without DrugBank identifier
    Multiple chemicals in Infobox drug
    Chemicals using indexlabels
    Chemical articles with multiple CAS registry numbers
    Articles containing unverified chemical infoboxes
    Articles containing Russian-language text
    Wikipedia articles needing clarification from November 2020
    All stub articles
     



    This page was last edited on 4 February 2024, at 05:16 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki